Clinical Trials on Metastatic Transitional Cell Carcinoma
Total 14142 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingTransitional Cell Carcinoma | Metastatic Urothelial Carcinoma | Unresectable Transitional Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Metastatic Transitional Cell CarcinomaUnited States
-
AIO-Studien-gGmbHBristol-Myers SquibbActive, not recruitingTransitional Cell Carcinoma | Metastatic Cancer | Advanced CancerGermany, Austria
-
Shaheen AlaneeMerck Sharp & Dohme LLCUnknownEndoscopic Surgical Procedure | High Risk Superficial Upper Urinary Tract Transitional Cell Carcinoma | Transitional Epithelial CellsUnited States
-
Cliniques universitaires Saint-Luc- Université...NovartisTerminatedCarcinoma Transitional CellBelgium, Luxembourg
-
Associació per a la Recerca Oncologica, SpainUnknownUrothelium Transitional Cell CarcinomaSpain, Netherlands
-
National Taiwan University HospitalRecruiting
-
Vasgene Therapeutics, IncRecruitingMetastatic Urothelial CarcinomaUnited States
-
Spanish Oncology Genito-Urinary GroupAdknoma Health ResearchCompleted
-
Shandong New Time Pharmaceutical Co., LTDUnknownLocally Advanced or Metastatic Urothelial Cell Carcinoma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMetastatic Urothelial CarcinomaUnited States
-
UroGen Pharma Ltd.CompletedCarcinoma, Transitional Cell | Transitional Cell Carcinoma of Renal PelvisUnited States, Israel
-
Associació per a la Recerca Oncologica, SpainPivotal S.L.; Merck, S.L., SpainCompletedMetastatic Urothelial CancerSpain
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Sheba Medical CenterRecruiting
-
CHU de Quebec-Universite LavalCancer Research SocietyWithdrawnMetastatic Urothelial CarcinomaCanada
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Urothelial CarcinomaItaly
-
UNC Lineberger Comprehensive Cancer CenterPfizerTerminatedMetastatic Urothelial Carcinoma (UC)United States
-
M.D. Anderson Cancer CenterRecruitingMetastatic MalignancyUnited States
-
Associació per a la Recerca Oncologica, SpainTakeda; Pivotal S.L.Unknown
-
Institute of Cancer Research, United KingdomCancer Research UKUnknownTransitional Cell Carcinoma of UreterUnited Kingdom
-
Roswell Park Cancer InstituteIovance Biotherapeutics, Inc.WithdrawnMetastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Unresectable Renal Pelvis Urothelial Carcinoma | Unresectable Ureter Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Transitional Cell Carcinoma of the Bladder | Localized Transitional Cell Cancer of the...United States
-
Spanish Oncology Genito-Urinary GroupRoche Pharma AGCompletedLocally Advanced or Metastatic Urothelial CarcinomaSpain
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingLocally Advanced or Metastatic Urothelial CarcinomaChina
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Urothelial Carcinoma | Urothelial NeoplasmsAustralia, United States, Canada, Chile, France, Israel, Italy, Korea, Republic of, Netherlands, Spain, Taiwan, United Kingdom
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Taiho Oncology, Inc.Merck Sharp & Dohme LLCActive, not recruitingAdvanced and Metastatic Urothelial CancerSpain, United States, France
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedTransitional Cell Carcinoma of Urinary TractNetherlands
-
Astellas Pharma Global Development, Inc.Seagen Inc.Approved for marketingLocally Advanced or Metastatic Urothelial Carcinoma (UC)United States
-
Bernie EiglLady Davis Institute; Vancouver Prostate Centre; Bladder Cancer CanadaRecruitingMetastatic Urothelial Carcinoma | Metastatic Bladder CancerCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingMetastatic Urothelial CarcinomaChina
-
Shanghai Miracogen Inc.RecruitingMetastatic Urothelial Carcinoma | Locally Advanced Urothelial CancerChina
-
Fox Chase Cancer CenterRecruitingUrothelial Carcinoma | Metastatic Urothelial Carcinoma | Locally Advanced Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterRecruitingMetastatic Cancer | Urothelial CarcinomaUnited States
-
Yale UniversityWithdrawnTransitional Cell CarcinomaUnited States
-
Chinese PLA General HospitalCompleted
-
Lahey ClinicWithdrawnTransitional Cell CarcinomaUnited States
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Far Eastern Memorial HospitalUnknownCarcinoma, Transitional CellTaiwan
-
AdventHealthJazz PharmaceuticalsRecruitingMetastatic Cancer | Urothelial CarcinomaUnited States
-
Principia Biopharma, a Sanofi CompanyTerminatedSolid Tumors | Metastatic Urothelial Carcinoma & Renal Pelvis & UreterSpain, United States
-
UroGen Pharma Ltd.WithdrawnCarcinoma | Transitional Cell Carcinoma | Transitional Cell Cancer of the Renal Pelvis and UreterIsrael, United States
-
Kaohsiung Medical UniversityCompletedCarcinoma, Transitional Cell (RENI)
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Bladder Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Metastatic Renal Pelvis and Ureter Urothelial CarcinomaUnited States
-
Pierre Fabre MedicamentCompletedBladder Transitional Cell Carcinoma Stage IVFrance
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalCompletedGemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCCTransitional Cell CarcinomaTaiwan
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Bladder Carcinoma | Metastatic Urothelial Carcinoma | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage IV Bladder Urothelial Carcinoma AJCC v7 | Locally Advanced Bladder Urothelial Carcinoma | Metastatic Transitional Cell CarcinomaUnited States